100 reports

  • A) Global diabetes and obesity market
  • Diabetes an d obesity
  • Obesity
  • World
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • Anti-obesity drugs Industry
  • Anti-Obesity Drug Industry Structure
  • Obesity
  • China
  • Abbott Laboratories, Inc.
  • Beijing Outsell Health Product Development Co., Ltd.
  • Shanghai Jahwa United Co., Ltd.
  • Anti-obesity Drugs Imports
  • Anti-obesity Drugs Exports
  • Obesity
  • Pathology
  • China
  • Demand
  • Abbott Laboratories, Inc.
  • Obesity 2021
  • Relationship between wealth and obesity
  • Obesity
  • Pathology
  • Weight Loss
  • United Kingdom
  • Demand

Key Features of the Report: - Obesity Patient Flow - Obesity Prevalence - Obesity Diagnosed Patients - Obesity Treated Patients

  • Obesity
  • Pathology
  • Europe
  • World
  • Forecast

Global Anti-Obesity Prescription Drugs Market Overview ##. ##.

  • Obesity
  • Pathology
  • Prescription Drug
  • World
  • Market Size

Introduction to Obesity ##. ## What is Obesity?

  • Obesity
  • Pathology
  • World
  • Forecast

The obesity management market should grow as obesity is too big a condition to ignore The prevalence of obesity has nearly doubled in the years since 1980.

  • Obesity
  • Pathology
  • North America
  • World
  • Forecast
  • Anti-obesity drugs Industry
  • Anti-Obesity Drug Industry Structure
  • Obesity
  • China
  • Abbott Laboratories, Inc.
  • Beijing Outsell Health Product Development Co., Ltd.
  • Shanghai Jahwa United Co., Ltd.

Worldwide, obesity has more than doubled since 1980.

  • Obesity
  • Pathology
  • World
  • Market Size

Obesity Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Obesity Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Obesity pipeline products, Obesity epidemiology, Obesity market v

  • Obesity
  • France
  • Germany
  • Italy
  • Market Size

The boost in demand for the obesity surgery devices is due to various factors such as increasing prevalence of obesity leading to high demand for obesity surgeries, rising awareness about bariatric surgery in obese population, lifestyle changes leading to high ris

  • Obesity
  • Asia
  • World
  • Forecast
  • Market Size

Growing global prevalence of obesity ##. ##. ##. ##.

  • Obesity
  • Pathology
  • World
  • Forecast
  • Market Size

Key Features of the Report: - Obesity Patient Flow - Obesity Prevalence - Obesity Diagnosed Patients - Obesity Treated Patients

  • Obesity
  • Europe
  • France
  • Germany
  • Forecast

Obesity Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Obesity Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Obesity pipeline products, Obesity epidemiology, Obesity market valu

  • Obesity
  • Europe
  • France
  • Germany
  • Market Size
  • 4.2 ADOLESCENT AND CHILDHOOD BARIATRIC SURGERIES
  • 2.1 CATALYST
  • Medical Device
  • Obesity
  • World
  • Ethicon, Inc.
  • Medtronic, Inc.

Japan Obesity Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Obesity Treatments ##) Obesity Pipeline ##) Japan Obesity Epidemiology ##) Marketed Drugs for Obesity in Japan ##) Japan

  • Obesity
  • Pathology
  • Weight Loss
  • Japan
  • Market Size

Italy Obesity Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Obesity Treatments ##) Obesity Pipeline ##) Italy Obesity Epidemiology ##) Marketed Drugs for Obesity in Italy ##) Italy

  • Obesity
  • Pathology
  • Weight Loss
  • Italy
  • Market Size

Germany Obesity Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Obesity Treatments ##) Obesity Pipeline ##) Germany Obesity Epidemiology ##) Marketed Drugs for Obesity in Germany ##) German

  • Obesity
  • Pathology
  • Weight Loss
  • Germany
  • Market Size

UK Obesity Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Obesity Treatments ##) Obesity Pipeline ##) UK Obesity Epidemiology ##) Marketed Drugs for Obesity in UK ##) UK Obesity M

  • Obesity
  • Pathology
  • Weight Loss
  • United Kingdom
  • Market Size

France Obesity Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Obesity Treatments ##) Obesity Pipeline ##) France Obesity Epidemiology ##) Marketed Drugs for Obesity in France ##) France

  • Obesity
  • Pathology
  • Weight Loss
  • France
  • Market Size

Spain Obesity Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Obesity Treatments ##) Obesity Pipeline ##) Spain Obesity Epidemiology ##) Marketed Drugs for Obesity in Spain ##) Spain

  • Obesity
  • Pathology
  • Weight Loss
  • Spain
  • Market Size

US Obesity Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Obesity Treatments ##) Obesity Pipeline ##) US Obesity Epidemiology ##) Marketed Drugs for Obesity in US ##) US Obesity M

  • Obesity
  • Pathology
  • Weight Loss
  • Market Size
  • Month & Year
  • ROAPAC: BODY COMPOSITION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • Obesity
  • Hologic, Inc.
  • InBody Co., Ltd.
  • Omron Corporation
  • Tanita Corporation
  • Increasing focus of governments to reduce obesity in developed countries
  • MARKET DRIVERS
  • Gastroenterology
  • Obesity
  • World
  • Forecast
  • Medtronic, Inc.

Anti-obesity pharmacotherapy can be used as an adjunct lifestyle modification to improve weight loss in order to significantly reduce obesity-associated health risks in obese patients.

  • Obesity
  • Pathology
  • GLOBAL OBESITY DRUGS MARKET 2016-2021 ($ BILLIONS)
  • Depression
  • Obesity
  • Allergan plc
  • Eli Lilly & Co.
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Anti-obesity Drugs Market in the US
  • Anti-obesity Drugs Market in the US
  • Obesity
  • United States
  • Arena Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Obesity Drugs
  • Obesity Drugs
  • Obesity
  • United States
  • EnteroMedics Inc.
  • Novo Nordisk Group
  • VIVUS, Inc.
  • 3.5.4.3 Prevalent Cases of Obesity Among the Diagnosed Prevalent Cases of T2D
  • MM, Sources Used, Prevalent Cases of Obesity Among the Diagnosed Prevalent Cases of T2D
  • Obesity
  • France
  • Germany
  • Spain
  • Forecast